This study evaluates the clinical value of a deep learning–based artificial intelligence (AI) system that performs rapid brain volumetry with automatic lobe segmentation and age- and sex-adjusted percentile comparisons.<br>Methods: Fifty-five patients—17 with Alzheimer’s disease (AD), 18 with frontotemporal dementia (FTD), and 20 healthy controls—underwent cranial magnetic resonance imaging scans. Two board-certified neuroradiologists (BCNR), two board-certified radiologists (BCR), and three radiology residents (RR) assessed the scans twice: first<br>without AI support and then with AI assistance.<br>Results: AI significantly improved diagnostic accuracy for AD (area under the curve −AI: 0.800, +AI: 0.926, p < 0.05), with increased correct diagnoses (p < 0.01) and reduced errors (p < 0.03). BCR and RR showed notable performance gains (BCR:<br>p < 0.04; RR: p < 0.02). For the diagnosis FTD, overall consensus (p < 0.01), BCNR (p < 0.02), and BCR (p < 0.05) recorded significantly more correct diagnoses.<br>Discussion: AI-assisted volumetry improves diagnostic performance in differentiating AD and FTD, benefiting all reader groups, including BCNR.
article
BibTeXKey: RRD+24